Under the agreement, Allergan will pay $1.9 million to Summit County, Ohio, and $3.1 million to Cuyahoga County, Ohio. The two Ohio counties were chosen to serve as bellwethers in litigation over the opioid epidemic.
Endo International reached an $11 million settlement in August with the two counties.
Allergan and Endo are two of the smaller drugmakers named as defendants in the October trial. Other drugmakers are Purdue Pharma, Teva Pharmaceuticals and Johnson & Johnson.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.